Intermittent therapy for extrapulmonary tuberculosis.
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007198:Indians, North American; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014395:Peritonitis, Tuberculous / Q000188:drug therapy; D011736:Pyridoxine / Q000627:therapeutic use; D012002:Rectal Diseases / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014385:Tuberculosis, Gastrointestinal / Q000188:drug therapy; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000188:drug therapy; D014398:Tuberculosis, Renal / Q000188:drug therapy; D014401:Tuberculosis, Urogenital / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D013307:Streptomycin